Regentis Biomaterials Stock: Surgeon Training for GelrinC Knee Implant Set for Q3
Regentis Biomaterials shares fell slightly premarket after announcing European surgeon training for its GelrinC knee implant will start in Q3, a commercial milestone but not yet revenue.
Technology